ANNUAL REPORT 2007/08
Tamro in Brief
CEO's Review
Corporate Governance
  Group Management
Financial Risk Management
Corporate Responsibility
Human Resources
BUSINESS UNITS
FINANCIAL STATEMENTS
Board of Directors' Report
  Board of Directors
Consolidated Income Statement
Consolidated Balance Sheet
Consolidated Cash Flow Statement
Income Statement of the Parent Company
Balance Sheet of the Parent Company
Cash Flow Statement of the Parent Company
Accounting Principles
Notes to the Financial Statements
Proposal for Profit Distribution
Auditors' Report
Financial Indicators 2003-2007/08
Calculation of Financial Ratios
Quarterly Development
Site Map/
Download Centre
 
 
 
  Index Home
  Back Back
  Info Instructions
  Print Print
Notes to the Financial Statement
 
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 1-10
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 11-20
NOTES TO THE PARENT COMPANY FINANCIAL STATEMENTS 21-30
NOTES TO THE PARENT COMPANY FINANCIAL STATEMENTS 31-44
 
Displaying Notes 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 out of total 44 notes
(Figures are in EUR thousands unless otherwise stated) 31 Jan 2008 31 Jan 2007
     
NOTES TO THE CONSOLIDATED INCOME STATEMENT    
     
1. NET SALES BY MARKET AREA AND UNIT, EUR MILLION
     
By market area:    
 Sweden 1,694.0 1,740.0
 Denmark 1,435.7 1,309.2
 Finland 1,036.5 1,068.9
 Norway 744.1 731.6
 Poland 361.6 347.8
 Baltic States 283.4 266.5
 Others 49.9 0,5
  5,605.2 5,464.5
By unit:
 Tamro Sweden 1,685.7 1,708.4
 Tamro Denmark 1,526.1 1,334.8
 Tamro Finland 1,032.4 1,040.6
 Tamro Norway 765.5 723.2
 Tamro Poland 362.7 347.9
 Tamro Baltics 289.5 270.4
 Tamro MedLab - 61.2
 Others -56.7 -22.0
  5,605.2 5,464.5
     
2. OTHER INCOME
     
Gain on sale of fixed assets 3,638 6,302
     
3. RAW MATERIALS AND SERVICES
     
Raw materials and consumables    
  Purchases during the financial period 5,148,575 5,050,168
  Inventories, incr. (-), decr. (+) -33,940 -52,588
External services 29,571 30,615
Raw materials and services total 5,144,206 5,028,195
   

4. PERSONNEL EXPENSES
     
Average personnel by unit:    
  Tamro Sweden 444 440
  Tamro Denmark 620 634
  Tamro Finland 331 335
  Tamro Norway 1,905 1,803
  Tamro Poland 359 321
  Tamro Baltics 1,053 1,003
  Tamro MedLab - 133
  Others 24 24
  4,736 4,693
Personnel expenses:    
Wages and salaries during the financial year 173,584 160,696
Payroll related social costs
  Pension costs 11,673 9,604
  Other payroll related social costs 26,034 24,251
  211,291 194,551
Wages and salaries paid to:    
  Boards of Directors, CEO and Managing Directors 4,213 4,866
     
Pension commitments for Board Members, CEO and Managing Directors: The parent company has no pension liabilities for Board Members. The pensionable age of the CEO has been stipulated at 60 years.  
 
Other pension commitments:
The Group has no significant pension commitments for the management.
 
 
5. DEPRECIATION AND VALUE ADJUSTMENTS
     
Depreciation/amortisation according to plan    
  Intangible rights 925 912
  Goodwill 12,706 11,661
  Consolidated goodwill -401 1,045
  Other capitalised expenditure 91 165
  Buildings 7,410 7,396
  Machinery and equipment 11,281 12,248
  Other tangible assets 324 308
  32,336 33,735
 
6. FINANCIAL INCOME AND EXPENSES 31 Jan 2008 31 Jan 2007
     
Income from non-current financial assets
 
  Dividend income 4,330 653
  Interest income - 968
Other interest and financial income    
  Interest income 2,845 2,024
Other interest and financial expenses    
  Interest expenses -5,784 -6,707
  Other financial expenses -3,981 -2,965
  Exchange rate differences, net 721 -177
  -1,869 -6,204
     
7.EXTRAORDINARY INCOME AND EXPENSES
     
  Gain on sale of MedLab business - 48,496
   

8. INCOME TAXES
     
Income taxes on ordinary activities    
  Finnish Group companies -2,771 -3,658
  Foreign Group companies -28,353 -17,037
  -31,124 -20,695
Income taxes from previous years 3,416 -73
Change in deferred tax liability specified in note 20 -4,156 -12,480
Income taxes total -31,864 -33,248
     
NOTES TO THE CONSOLIDATED BALANCE SHEET
 
9. FIXED ASSETS
  Intangible assets Tangible assets
  Intangible
rights
Goodwill Consoli-
dated goodwill 1
Other capital-
ised expen-
diture
Advance pay-
ments
and cons-
truction
in progress
Land areas Buildings Machinery
and
equipment
Other
tangible
assets
Advance pay-
ments
and cons-
truction
in progress
Acquisition value 1 Feb 2007 15,165 213,705 58,068 6,330 2,279 9,403 164,479 148,778 2,649 463
Increase 1,053 7,295 1,580 997 1,173 64 8,643 11,515 404 4,927
Decrease -8,728 -97 0 -1,729 -1 0 -4,063 -2,007 -101 0
Other changes 1,376 0 0 0 -1,284 1 -4,163 -26,297 75 -4,390
Translation difference -41 1,575 59 19 0 -79 -568 -830 5 3
Acquisition value 31 Jan 2008 8,825 222,478 59,707 5,617 2,167 9,389 164,328 131,159 3,032 1,003
   
Accumulated depr. 1 Feb 2007 -13,141 -44,746 -53,896 -5,765 0 0 -70,257 -115,905 -1,306 0
Depreciation during period -925 -12,706 401 -91 0 0 -7,410 -11,281 -324 0
Increase -4 0 -1 0 0 0 -17 -91 -71 0
Decrease  8,693 0 0 1,698 0 0 2,680 1,693 66 0
Other changes -43 0 0 0 0 0 7,488 27,231 6 0
Translation difference 43 -241 0 -19 0 0 212 493 -2 0
Accumulated depr. 31 Jan 2008 -5,377 -57,693 -53,496 -4,177 0 0 -67,304 -97,860 -1,631 0
                     
Value adjustments 1 Feb 2007 & 31 Jan 2008         420 2,355      
                     
Book value 31 Jan 2008 3,448 164,785 6,211 1,440 2,167 9,809 99,379 33,299 1,401 1,003
   
Book value 31 Jan 2007 2,024 168,959 4,172 565 2,279 9,823 96,577 32,873 1,343 463
                     
1 Consolidated goodwill comprises of consolidated goodwill and consolidated negative goodwill ("badwill"). As at February 1, 2007, cost of consolidated goodwill amounted to EUR 63,887,000 and accumulated amortisation was EUR -54,259,000, and cost of consolidated negative goodwill was EUR -5,819,000 and accumulated amortisation was EUR 363,000. During the period, consolidated goodwill was amortised by EUR -1,055,000 and consolidated negative goodwill was amortised by EUR 1,455,000. As at 31 Jan 2007, the book value of consolidated goodwill and consolidated negative goodwill amounted to EUR 9,628,000 and EUR -5,456,000, respectively. As at 31 Jan 2008, the book value of consolidated goodwill and consolidated negative goodwill amounted to EUR 10,212,000 and EUR -4,001,000, respectively.

Value adjustments relate to the parent company only (from 1988). Deferred tax liability (EUR 722,000) has not been accounted for. Value adjutments related to fixed assets are not considered as a normal accounting practice of the Group.

  31 Jan 2008 31 Jan 2007
     
Machinery and equipment in production use, book value 171 7
     
10. ASSOCIATED COMPANIES
     
Opening balance 16,996 4,151
     
  New associated companies - 14,814
  Write-down of the shares - -243
  Associated companies converted into subsidiaries -27 -1,907
  Share of net results 232 206
  Received dividends -88 -
  Translation differences 16 -8
  Other differences 9 -17
Closing balance 17,138 16,996
     
  Group sharere
of holding %
Parent
company
share
of holding %
     
OÜ Mai Apteek, Pärnu, Estonia 49.0 -
Svolvaer Apotek AS, Svolvaer, Norway 49.0 -
ZAO Rosta 42.5 42.5
Namsos Apotek AS, Namsos, Norway 34.0 -
OÜ Ravikeskuse, Viimsi, Estonia 33.0 -
     
The associated companies have been consolidated using the equity method. The share of ZAO Rosta's result is not included as it is unfeasible to receive the financial information within the set timeframe for preparing the group accounts. Included in the associated companies is undepreciated goodwill amounting to EUR 1,069 thousand.
     
Other shares and participations    
     
Golf shares 83  
OMX Plc 27  
Telephone company shares etc. 7  
Real estate and other shares 169  
  286  
 
Displaying Notes 1, 2, 3, 4, 5, 6, 7, 8. 9, 10 out of total 44 notes
  Tamro Web Annual Report 2007/08. Published 30 April 2008. Copyright © Tamro Corporation 2008. All rights reserved.